US Patent Issued to Brii Biosciences on July 29 for "Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof" (North Carolina Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,200, issued on July 29, was assigned to Brii Biosciences Inc. (Durham, N.C.).

"Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof" was invented by Robert G. Strickley (Durham, N.C.), Lianhong Xu (Durham, N.C.) and Zhi Hong (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a pharmaceutical composition comprising a pharmaceutically effective amount of a neuroactive steroid that is a positive modulator of Gamma aminobutyric acid type A (GABAA) receptors. Also disclosed are methods of treating diseases using the pharmaceutical composition and processes of producing the pharmaceuti...